Nadav Kidron - 09 Aug 2021 Form 4/A - Amendment Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Nadav Kidron
Issuer symbol
ORMP
Transactions as of
09 Aug 2021
Net transactions value
-$4,423,144
Form type
4/A - Amendment
Filing time
07 Dec 2021, 15:30:31 UTC
Date Of Original Report
11 Aug 2021
Next filing
07 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Sale $4,423,144 -220,000 -23% $20.11* 738,209 09 Aug 2021 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 18, 2021.
F2 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 18, 2021.
F3 This amendment is being filed to correct an administrative error in Form 4 filed by Mr. Kidron, which reported that 648,573 shares of common stock are beneficially owned by him following the reported transaction. Mr. Kidron beneficially owned 738,209 shares of common stock following the reported transaction.